Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
Breakthrough Technology: Success of Barcodes on Vaccine Inventory Management
Rehana Wolfe, Pfizer
Director, Developing World, Vaccines at Pfizer
April 4-6, 2017
© GS1 2017
Introduction
2
Rehana Wolfe, M.A.Vaccine Lead, Global Developing WorldResponsible for the introduction and support of PCV 13 vaccination programs in Gavi Eligible Countries in the Pfizer-Gavi Partnership
© GS1 2017
Agenda
3
• Background
• The Challenge
• A Solution
• Pfizer’s 2D Barcode Pilot Program
• Partnership
• Conclusion
© GS1 2017 4
Background
Children in developing countries are ten times more likely to die before the age of five than children in developed countries.
© GS1 2017 5
Background
Simple interventions can save many young lives each year.
Clean Water
Vaccination
Nutrition
© GS1 2017 6
The Challenge
Are vaccines getting to the children in need?
© GS1 2017 7
A Solution - Barcodes
A focus on vaccine presentation and packaging.
© GS1 2017 8
Why a Barcode?
All system data is hosted centrally on a server – no need for local system copies at each site location
Scanning the 2D barcode will eliminate human data entry errors
Scanning will speed up data entry
Real-time inventory reporting allows for quicker decision-making at intermediate and central levels
Accuracy Efficiency
Visibility Data Security
© GS1 2017 9
Barcode Landscape in the Developing World
Barcode Proof of
Principle in Tanzania
Ethiopia Pilot for E2E
Supply Chain Visibility
Implementation of GS1
Standards in Pakistan
© GS1 2017 10
Pfizer’s 2D Barcode Pilot Program
• Demonstrate compelling evidence and advance the dialogue
• Enrich open-source supply chain solutions
• Accelerate impact on global health
Program Objectives
PILOT SITES
1. Cenabi
2. Managua
3. Masaya
4. León
5. Francisco Buitrago
6. Masatepe
7. Mantica Berio
National StoreCentral level
Districts/SILAISSecondary Level
MunicipalitiesTertiary level
Health Centers*Last Mile
© GS1 2017
Implementation Methodology
11
PILOT
EVALUATION*
PILOT
MONITORING
DEPLOY &
PILOT
BUILD & TEST
DESIGN
SCOPING &
PLANNING
July2015
Aug 2015
Sept 2015
Oct & Nov2015
Dec2015
Jan-Apr2016
*Pilot Extension through April 2016
Pilot period extended
Feedback gathering
Monitored system usage directly after go-live
Continued to troubleshoot system issues on an ongoing basis
Rolled out 2D barcoding solution to 7 sites
Conducted user training
Completed system development
Delivered finalized technical design specifications
Reviewed current MoH processes
Conducted gap assessment
© GS1 2017
Results
12
• All system data hosted centrally
• Removes need for local system copies at each site location, reducing data management costs and possible security breaches
Accuracy Efficiency
Data Security
Total number of adjustments made across all
levels:
One in 223 Transactions
Visibility and Operational
Ability to see stocks at all levels:
All levels of system used
100%
Manual entry: 1 minuteScanned entry: 18 seconds
68% less time needed for one transaction vs. manual system
© GS1 2017 13
Call to Action
It’s time to partner together – both governments and pharmaceutical companies – to operationalize and improve technology for the most impact.
What We Need:
• Government participation
• Pharma EPI programs alignment
• Alliance partners engagement
• Get the message out!
• Make this a priority
© GS1 2017 14
Conclusion
Barcode technology can increase access to potentially life saving vaccines.
© GS1 2017 15
Thank You!
All of the opinions expressed in this presentation are mine and do not necessarily reflect the opinion of Pfizer
© GS1 2017 16
Q&A Session
© GS1 2017
Contact Information
17
Rehana B. Wolfe
Director, Developing World, Vaccines at Pfizer
+1 (484) 865-5517
www.gs1.org
Pfizer
500 Arcola Road
Collegeville, PA 19468
+1 (484) 524-3717
T
M
E